COPB2 and cancer: Here, we observed a correlation between COPB2 transcript levels and immunosuppressive cell types—such as Tregs, neutrophils, and MDSCs (Figure 5B)—which might exhibit immunosuppressive activities and leading to adverse clinical outcomes in patients with cancer.